Sanofi (SAN.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 8,937,000 | 8,923,000 | 9,172,000 | 8,771,000 | 8,192,000 |
| Cost of Goods | 2,627,000 | 2,793,000 | 2,895,000 | 2,850,000 | 2,364,000 |
| Gross Profit | 6,310,000 | 6,130,000 | 6,277,000 | 5,921,000 | 5,828,000 |
| Operating Expenses | 4,189,000 | 4,344,000 | 3,866,000 | 4,411,000 | 4,348,000 |
| Operating Income | 2,121,000 | 1,786,000 | 2,411,000 | 1,510,000 | 1,480,000 |
| Interest Expense | 139,000 | 165,000 | 153,000 | 133,000 | 101,000 |
| Other Income | 105,000 | -791,000 | -45,000 | -381,000 | -99,000 |
| Pre-tax Income | 2,087,000 | 830,000 | 2,213,000 | 996,000 | 1,280,000 |
| Income Tax | 496,000 | -415,000 | 398,000 | 203,000 | 269,000 |
| Net Income Continuous | 1,880,000 | 1,490,000 | 2,084,000 | 1,064,000 | 1,296,000 |
| Minority Interests | -53,000 | -51,000 | -54,000 | -58,000 | -78,000 |
| Net Income | $1,827,000 | $1,439,000 | $2,030,000 | $1,006,000 | $1,218,000 |
| EPS Basic Total Ops | 1.38 | 1.08 | 1.52 | 0.77 | 0.93 |
| EPS Basic Continuous Ops | 1.38 | 1.08 | 1.52 | 0.77 | 0.93 |
| EPS Diluted Total Ops | 1.38 | 1.06 | 1.52 | 0.74 | 0.93 |
| EPS Diluted Continuous Ops | 1.38 | 1.06 | 1.52 | 0.74 | 0.93 |
| EBITDA(a) | $3,059,000 | $1,804,000 | $3,170,000 | $2,062,000 | $2,149,000 |